Phosphatidylinositol-3,5-bisphosphate: Metabolism and physiological functions

Journal of Biochemistry

Volumn 154, Issue 3, 2013, Pages 211-218

  Takasuga, Shunsuke ^a   Sasaki, Takehiko ^a  

^a AKITA UNIVERSITY   (Japan)

Author keywords

Fig4; phosphatidylinositol 3,5 bisphosphate; PIKfyve; PipkIII; Sac3

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; MTM1 PROTEIN; MUTANT PROTEIN; MYOTUBULARIN RELATED PROTEIN 13; MYOTUBULARIN RELATED PROTEIN 14; MYOTUBULARIN RELATED PROTEIN 2; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL 3,5 BISPHOSPHATE; PHOSPHATIDYLINOSITOL KINASE; PHOSPHATIDYLINOSITOL MONOPHOSPHATE KINASE TYPE III; PROTEIN; RYANODINE RECEPTOR 1; SAC3 PROTEIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL; UNCLASSIFIED DRUG; VAC14 PROTEIN;

BODY SIZE; BRAIN DEGENERATION; CELL VACUOLE; CENTRONUCLEAR MYOPATHY; CORNEA CELL; CORNEA DYSTROPHY; EMBRYONIC STEM CELL; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EXON; FIBROBLAST; FLECK CORNEAL DYSTROPHY; GAIT DISORDER; GENE MUTATION; GENE SILENCING; GENE TARGETING; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; KNOCKOUT GENE; LETHALITY; LIPID METABOLISM; LOXP SITE; MUSCLE ATROPHY; MUSCLE HYPOTONIA; MUSCLE WEAKNESS; NERVE CELL DEGENERATION; NERVE DEGENERATION; NONHUMAN; PERIPHERAL NEUROPATHY; PHENOTYPE; PHOSPHORYLATION AND DEPHOSPHORYLATION; PHYSIOLOGY; PIGMENTATION; POINT MUTATION; REVIEW; SARCOPLASMIC RETICULUM; SCHWANN CELL; SKELETAL MUSCLE; SPONTANEOUS MUTATION; TONIC IMMOBILITY; TREMOR; YEAST;

FIG4; PHOSPHATIDYLINOSITOL-3,5-BISPHOSPHATE; PIKFYVE; PIPKIII; SAC3;

ANIMALS; CHARCOT-MARIE-TOOTH DISEASE; CORNEAL DYSTROPHIES, HEREDITARY; GENE EXPRESSION REGULATION; HUMANS; MUTATION; MYOPATHIES, STRUCTURAL, CONGENITAL; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR; SIGNAL TRANSDUCTION;

EID: 84883479005     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvt064     Document Type: Review

References (35)

1. Dove, S.K., Cooke, F.T., Douglas, M.R., Sayers, L.G., Parker, P.J., and Michell, R.H. (1997) Osmotic stress activates phosphatidylinositol-3,5- bisphosphate synthesis. Nature 390, 187-192
2. Whiteford, C.C., Brearley, C.A., and Ulug, E.T. (1997) Phosphatidylinositol 3,5-bisphosphate defines a novel PI 3-kinase pathway in resting mouse fibroblasts. Biochem. J. 323, 597-601
3. Sasaki, T., Takasuga, S., Sasaki, J., Kofuji, S., Eguchi, S., Yamazaki, M., and Suzuki, A. (2009) Mammalian phosphoinositide kinases and phosphatases. Prog. Lipid Res. 48, 307-343
4. Robinson, F.L. and Dixon, J.E. (2006) Myotubularin phosphatases: Policing 3-phosphoinositides. Trends Cell Biol. 16, 403-412
5. Odorizzi, G., Babst, M., and Emr, S.D. (1998) Fab1p PtdIns(3)P 5-kinase function essential for protein sorting in the multivesicular body. Cell 95, 847-858
6. Michell, R.H., Heath, V.L., Lemmon, M.A., and Dove, S.K. (2006) Phosphatidylinositol 3,5-bisphosphate: Metabolism and cellular functions. Trends Biochem. Sci. 31, 52-63
7. Takasuga, S., Horie, Y., Sasaki, J., Sun-Wada, G.H., Kawamura, N., Iizuka, R., Mizuno, K., Eguchi, S., Kofuji, S., Kimura, H., Yamazaki, M., Horie, C., Odanaga, E., Sato, Y., Chida, S., Kontani, K., Harada, A., Katada, T., Suzuki, A., Wada, Y., Ohnishi, H., and Sasaki, T. (2013) Critical roles of type III phosphatidylinositol phosphate kinase in murine embryonic visceral endoderm and adult intestine. Proc. Natl Acad. Sci. U. S. A. 110, 1726-1731
8. Li, S., Tiab, L., Jiao, X., Munier, F.L., Zografos, L., Frueh, B.E., Sergeev, Y., Smith, J., Rubin, B., Meallet, M.A., Forster, R.K., Hejtmancik, J.F., and Schorderet, D.F. (2005) Mutations in PIP5K3 are associated with Francois-Neetens mouchetee fleck corneal dystrophy. Am. J. Hum. Genet. 77, 54-63
9. Kotoulas, A., Kokotas, H., Kopsidas, K., Droutsas, K., Grigoriadou, M., Bajrami, H., Schorderet, D.F., and Petersen, M.B. (2011) A novel PIKFYVE mutation in fleck corneal dystrophy. Mol. Vis. 17, 2776-2781
10. Bolino, A., Muglia, M., Conforti, F.L., LeGuern, E., Salih, M.A., Georgiou, D.M., Christodoulou, K., Hausmanowa-Petrusewicz, I., Mandich, P., Schenone, A., Gambardella, A., Bono, F., Quattrone, A., Devoto, M., and Monaco, A.P. (2000) Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat. Genet. 25, 17-19
11. Azzedine, H., Bolino, A., Taieb, T., Birouk, N., Di Duca, M., Bouhouche, A., Benamou, S., Mrabet, A., Hammadouche, T., Chkili, T., Gouider, R., Ravazzolo, R., Brice, A., Laporte, J., and LeGuern, E. (2003) Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma. Am. J. Hum. Genet. 72, 1141-1153
12. Senderek, J., Bergmann, C., Weber, S., Ketelsen, U.P., Schorle, H., Rudnik-Schoneborn, S., Buttner, R., Buchheim, E., and Zerres, K. (2003) Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. Hum. Mol. Genet. 12, 349-356
13. Chow, C.Y., Zhang, Y., Dowling, J.J., Jin, N., Adamska, M., Shiga, K., Szigeti, K., Shy, M.E., Li, J., Zhang, X., Lupski, J.R., Weisman, L.S., and Meisler, M.H. (2007) Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Nature 448, 68-72
14. Laporte, J., Hu, L.J., Kretz, C., Mandel, J.L., Kioschis, P., Coy, J.F., Klauck, S.M., Poustka, A., and Dahl, N. (1996) A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat. Genet. 13, 175-182
15. Laporte, J., Biancalana, V., Tanner, S.M., Kress, W., Schneider, V., Wallgren-Pettersson, C., Herger, F., Buj-Bello, A., Blondeau, F., Liechti-Gallati, S., and Mandel, J.L. (2000) MTM1 mutations in X-linked myotubular myopathy. Hum. Mutat. 15, 393-409
16. Tosch, V., Rohde, H.M., Tronchere, H., Zanoteli, E., Monroy, N., Kretz, C., Dondaine, N., Payrastre, B., Mandel, J.L., and Laporte, J (2006) A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy. Hum. Mol. Genet. 15, 3098-3106
17. Amoasii, L., Bertazzi, D.L., Tronchere, H., Hnia, K., Chicanne, G., Rinaldi, B., Cowling, B.S., Ferry, A., Klaholz, B., Payrastre, B., Laporte, J., and Friant, S. (2012) Phosphatase-dead myotubularin ameliorates x-linked centronuclear myopathy phenotypes in mice. PLoS Genet. 8, e1002965
18. Ikonomov, O.C., Sbrissa, D., Delvecchio, K., Xie, Y., Jin, J.P., Rappolee, D., and Shisheva, A. (2011) The phosphoinositide kinase PIKfyve is vital in early embryonic development: Preimplantation lethality of PIKfyve-/- embryos but normality of PIKfyve+/- mice. J. Biol. Chem. 286, 13404-13413
19. Zolov, S.N., Bridges, D., Zhang, Y., Lee, W.W., Riehle, E., Verma, R., Lenk, G.M., Converso-Baran, K., Weide, T., Albin, R.L., Saltiel, A.R., Meisler, M.H., Russell, M.W., and Weisman, L.S. (2012) In vivo, Pikfyve generates PI(3,5)P2, which serves as both a signaling lipid and the major precursor for PI5P. Proc. Natl Acad. Sci. U S A. 109, 17472-17477
20. Lenk, G.M., Ferguson, C.J., Chow, C.Y., Jin, N., Jones, J.M., Grant, A.E., Zolov, S.N., Winters, J.J., Giger, R.J., Dowling, J.J., Weisman, L.S., and Meisler, M.H. (2011) Pathogenic mechanism of the FIG4 mutation responsible for Charcot-Marie-Tooth disease CMT4J. PLoS Genet. 7, e1002104
21. Ferguson, C.J., Lenk, G.M., Jones, J.M., Grant, A.E., Winters, J.J., Dowling, J.J., Giger, R.J., and Meisler, M.H. (2012) Neuronal expression of Fig4 is both necessary and sufficient to prevent spongiform neurodegeneration. Hum. Mol. Genet. 21, 3525-3534
22. Zhang, Y., Zolov, S.N., Chow, C.Y., Slutsky, S.G., Richardson, S.C., Piper, R.C., Yang, B., Nau, J.J., Westrick, R.J., Morrison, S.J., Meisler, M.H., and Weisman, L.S. (2007) Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-bisphosphate, results in neurodegeneration in mice. Proc. Natl Acad. Sci. U S A. 104, 17518-17523
23. Jin, N., Chow, C.Y., Liu, L., Zolov, S.N., Bronson, R., Davisson, M., Petersen, J.L., Zhang, Y., Park, S., Duex, J.E., Goldowitz, D., Meisler, M.H., and Weisman, L.S (2008) VAC14 nucleates a protein complex essential for the acute interconversion of PI3P and PI(3,5)P(2) in yeast and mouse. EMBO J. 27, 3221-3234
24. Nicholson, G., Lenk, G.M., Reddel, S.W., Grant, A.E., Towne, C.F., Ferguson, C.J., Simpson, E., Scheuerle, A., Yasick, M., Hoffman, S., Blouin, R., Brandt, C., Coppola, G., Biesecker, L.G., Batish, S.D., and Meisler, M.H. (2011) Distinctive genetic and clinical features of CMT4J: A severe neuropathy caused by mutations in the PI(3,5)P(2) phosphatase FIG4. Brain 134, 1959-1971
25. Houlden, H., King, R.H., Wood, N.W., Thomas, P.K., and Reilly, M.M. (2001) Mutations in the 5' region of the myotubularin-related protein 2 (MTMR2) gene in autosomal recessive hereditary neuropathy with focally folded myelin. Brain 124, 907-915
26. Buj-Bello, A., Laugel, V., Messaddeq, N., Zahreddine, H., Laporte, J., Pellissier, J.F., and Mandel, J.L. (2002) The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice. Proc. Natl Acad. Sci. U S A. 99, 15060-15065
27. Bolino, A., Bolis, A., Previtali, S.C., Dina, G., Bussini, S., Dati, G., Amadio, S., Del Carro, U., Mruk, D.D., Feltri, M.L., Cheng, C.Y., Quattrini, A., and Wrabetz, L. (2004) Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesis. J. Cell Biol 167, 711-721
28. Bonneick, S., Boentert, M., Berger, P., Atanasoski, S., Mantei, N., Wessig, C., Toyka, K.V., Young, P., and Suter, U. (2005) An animal model for Charcot-Marie-Tooth disease type 4B1. Hum. Mol. Genet. 14, 3685-3695
29. Robinson, F.L., Niesman, I.R., Beiswenger, K.K., and Dixon, J.E. (2008) Loss of the inactive myotubularinrelated phosphatase Mtmr13 leads to a Charcot-Marie-Tooth 4B2-like peripheral neuropathy in mice. Proc. Natl Acad. Sci. U S A. 105, 4916-4921
30. Tersar, K., Boentert, M., Berger, P., Bonneick, S., Wessig, C., Toyka, K.V., Young, P., and Suter, U. (2007) Mtmr13/Sbf2-deficient mice: An animal model for CMT4B2. Hum. Mol. Genet. 16, 2991-3001
31. Shen, J., Yu, W.M., Brotto, M., Scherman, J.A., Guo, C., Stoddard, C., Nosek, T.M., Valdivia, H.H., and Qu, C.K. (2009) Deficiency of MIP/MTMR14 phosphatase induces a muscle disorder by disrupting Ca(2+) homeostasis. Nat. Cell Biol. 11, 769-776
32. Dong, X.P., Shen, D., Wang, X., Dawson, T., Li, X., Zhang, Q., Cheng, X., Zhang, Y., Weisman, L.S., Delling, M., and Xu, H. (2010) PI(3,5)P(2) controls membrane trafficking by direct activation of mucolipin Ca(2+) release channels in the endolysosome. Nat. Commun. 1, 38
33. Wang, X., Zhang, X., Dong, X.P., Samie, M., Li, X., Cheng, X., Goschka, A., Shen, D., Zhou, Y., Harlow, J., Zhu, M.X., Clapham, D.E., Ren, D., and Xu, H. (2012) TPC proteins are phosphoinositide- activated sodium-selective ion channels in endosomes and lysosomes. Cell 151, 372-383
34. Friant, S., Pecheur, E.I., Eugster, A., Michel, F., Lefkir, Y., Nourrisson, D., and Letourneur, F (2003) Ent3p Is a PtdIns(3,5)P2 effector required for protein sorting to the multivesicular body. Dev. Cell 5, 499-511
35. Rusten, T.E., Rodahl, L.M., Pattni, K., Englund, C., Samakovlis, C., Dove, S., Brech, A., and Stenmark, H. (2006) Fab1 phosphatidylinositol 3-phosphate 5-kinase controls trafficking but not silencing of endocytosed receptors. Mol. Biol. Cell 17, 3989-4001